SCHEMBL7692703

SCHEMBL7692703

Oc1cccc2ccc(/C=C/c3ccco3)nc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 15/20 0.60
▸ MEN1 O00255 14/20 0.60
▸ NPC1 O15118 13/20 0.60
▸ RAB9A P51151 11/20 0.60
▸ KDM4E B2RXH2 7/20 0.60
▸ MAPT P10636 6/20 0.60
▸ POLB P06746 2/20 0.60
▸ TDP1 Q9NUW8 2/20 0.60
▸ L3MBTL1 Q9Y468 2/20 0.60
▸ RECQL P46063 1/20 0.60
▸ BLM P54132 1/20 0.60
▸ MCL1 Q07820 1/20 0.60
▸ CD74 P04233 1/20 0.58
▸ MIF P14174 1/20 0.58
▸ SMN1; SMN2 Q16637 5/20 0.56
▸ HSP90AA1 P07900 5/20 0.55
▸ HTT P42858 4/20 0.55
▸ AGTR1 P30556 3/20 0.55
▸ LMNA P02545 4/20 0.52
▸ PKM P14618 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7692704 1.00 KMT2A (0.60) KMT2AMEN1NPC1RAB9AKDM4E
SCHEMBL7686285 0.77 PIM1 (0.66) KMT2AMEN1NPC1RAB9AKDM4E
SCHEMBL7686280 0.77 PIM1 (0.66) KMT2AMEN1NPC1RAB9AKDM4E
SCHEMBL3319480 0.75 CD74 (0.79) KMT2AMEN1NPC1RAB9AKDM4E
SCHEMBL3317100 0.75 CD74 (0.79) KMT2AMEN1NPC1RAB9AKDM4E
SCHEMBL6428720 0.74 CD74 (0.77) KMT2AMEN1NPC1RAB9AKDM4E
SCHEMBL8344151 0.74 CD74 (1.00) KMT2AMEN1NPC1RAB9AKDM4E
SCHEMBL28473985 0.73 CD74 (0.75) KMT2AMEN1NPC1RAB9AKDM4E
SCHEMBL28473988 0.73 CD74 (0.75) KMT2AMEN1NPC1RAB9AKDM4E
SCHEMBL16107255 0.72 KMT2A (0.61) KMT2AMEN1NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6500842-B1 N-((4-CHLOROPHENYL)METHYL)-8-HYDROXY-7-QUINOLINECARBOXAMIDE ADMINISTERED AS VIRICIDES AGAINST HERPES VIRUS PHARMACIA & UPJOHN COMPANY 2002-12-31 — — US disclosed
US-6310211-B1 ANTI-VIRAL ACTIVITY AGAINST HERPES VIRUS, CYTOMEGALOVIRUS. MANY OF THESE COMPOUNDS ARE ALSO ACTIVE AGAINST VARICELLA ZOSTER VIRUS, EPSTEIN-BARR VIRUS, HERPES SIMPLEX VIRUS AND HUMAN HERPES VIRUS TYPE 8 PHARMACIA & UPJOHN COMPANY 2001-10-30 — — US disclosed
US-6252080-B1 HERPES, CYTOMEGALO VIRUS PHARMACIA & UPJOHN COMPANY 2001-06-26 — — US disclosed
US-6211376-B1 HERPES VIRUS, CYTOMEGALO VIRUS, VARICELLA-ZOSTER VIRUS,EPSTEIN-BARR VIRUS PHARMACIA & UPJOHN COMPANY 2001-04-03 — — US disclosed
EP-0927164-A1 8-HYDROXY-7-SUBSTITUTED QUINOLINES AS ANTI-VIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 1999-07-07 — — EP disclosed
WO-1998011073-A1 8-HYDROXY-7-SUBSTITUTED QUINOLINES AS ANTI-VIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 1998-03-19 — — WO disclosed
Send feedback